drug

pivekimab sunirine-pvzy

1 story · latest Jul 31, 2026

Status: FDA approved May 2026 · BLA761460
Brand: Decnupaz

Relationships

Developed by AbbVie

Timeline

AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 results

Jul 31Quarterly updateAbbVie

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.